-
Amylin And Lilly Hope A New Byetta Study Eases Concern Over Drug-Safety Issues
Nonetheless, Pending Byetta Label Change Will Probably Add Stronger Warnings About Severe Pancreatitis Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) As some may recall, in August 2008 the FDA issued a MedWatch alert…
-
FDA’s “Sentinel Initiative” Project For Monitoring Medical Product Safety: March 2009 Update
Agency Publishes Notice In March 9 Edition Of The Federal Register: Seeking Public Comment On Proposed Voluntary Survey (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2008 the FDA published a white paper, "The…
-
Warnings About Byetta Associated With Risk Of Severe Pancreatitis And Renal Failure
March 2009 Drug Safety Update Newsletter (UK) Raises Emerging Safety Issue Of Kidney-Related Side Effects From Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATE: "Diabetes Drug Byetta Linked To Kidney Problems And Cases…
-
Avandia And Actos Are In Same Class, But One Of These Diabetes Drugs Has More Safety Risks
New Study Shows Older Diabetics Were More Likely To Develop Heart Failure Or Die When Using Avandia As Opposed To Actos (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Avandia Should Be Removed from…
-
Internal Glaxo Emails Show Drug Company Was Concerned In 2007 About Avandia’s Heart Attack Risks
Senator Grassley's Report On How Glaxo Defended Avandia In Wake Of 2007 NEJM Article By Nissen And Wolski Is Expected To Be Released Soon (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2007,…